바로가기메뉴

본문 바로가기 주메뉴 바로가기

Tuberculosis & Respiratory Diseases

Article Contents

Prev Next
e-Submission

Vol.58 No.2
Citation Share

Protective Efficacy of Recombinant Proteins Adenylate Kinase, Nucleoside Diphosphate Kinase, and Heat-Shock Protein 70 against ycobacterium tuberculosis Infection in Mice

Tuberculosis & Respiratory Diseases / Tuberculosis & Respiratory Diseases,
2005, v.58 no.2, pp.142-151






& (2005). Protective Efficacy of Recombinant Proteins Adenylate Kinase, Nucleoside Diphosphate Kinase, and Heat-Shock Protein 70 against ycobacterium tuberculosis Infection in Mice. Tuberculosis & Respiratory Diseases, 58(2), 142-151.
  • Downloaded
  • Viewed
PDF Download

Abstract

Background : Priming and boosting vaccination strategy has been widely explored for new vaccine development against tuberculosis. As an effort to identify other vaccine candidates, this study was initiated to evaluate protective efficacy of adenylate kinase (AK), nucleoside diphosphate kinase (NdK), and heat shock protein 70 (Hsp70) of Mycobacterium tuberculosis. Method : M. tuberculosis genes encoding AK, NdK, and Hsp70 proteins were amplified by PCR and cloned into E. coli expression vector, pQE30. Recombinant AK, NdK, and Hsp70 was purified through Ni-NTA resin. To evaluate immune responses, we performed enzyme-linked immunosorbent assay (ELISA) for IgG isotype and IFN-γ after mice were immunized subcutaneously with recombinant proteins delivered in dimethyl dioctadecylammonium bromide (DDA). Immunized- and control groups were challenged by aerosol with M. tuberculosis. The spleens and lungs of mice were removed aseptically and cultured for CFU of M. tuberculosis.Result : Vaccination with recombinant proteins AK, NdK, and Hsp70 delivered in DDA elicited significant level of antibody and IFN-γ responses to corresponding antigens but no protective immunity comparable to that achieved with Mycobacterium bovis BCG.Conclusion : Recombinant proteins AK, NdK, and Hsp70 do not effectively control growth of M. tuberculosis in mice when immunized with DDA as an adjuvant. (Tuberc Respir Dis 2005; 58:142-151)

keywords
Adenylate kinase, Nucleoside diphosphate kinase, Heat shock protein70, Mycobacterium tuberculosis, Protective efficacy

Reference

1.

(2003) A novel TB vaccine: strategies to combat a complex pathogen. ,

2.

(1995) Variation in protection by BCG implications of and for heterologous immunity. ,

3.

(1986) Results of a World Health Organization-sponsored workshop to characterise antigens recognised by mycobacterium-specific mo,

4.

(2002) Anderson P. A novel TB vaccine; towards a strategy based on our understanding of BCG failure.,

5.

(jexpmed1986) munoreactivity of a 70kD protein purified from Mycobacterium bovis bacillus Calmette-Guerin by monoclonal antibody affinity chromatography,

6.

(2001) Chakrabarty AM. Adenylate kinase as a virulence factor of Pseudomonas aeruginosa. ,

7.

(1990) T cell reactivity to the purified mycobacterial antigens p65 and p70 in leprosy patients and their household contacts,

8.

(1999) A new subfamily of short bacterial adenylate kinase with the Mycobacterium tuberculosis enzyme as a model,

9.

(1999) Comparative proteome analysis of Mycobacterium tuberculosis and Mycobacterium bovis BCG strains:towards functional genomics of microbial pathogens,

10.

(1998) Nucleoside diphosphate kinase: role in bacterial growth, virulence, cell signalling and polysaccharide synthesis,

11.

(2000) ESAT-6 subunit vaccination against Mycobacterium tuberculosis,

12.

(2002) Janin J. X- ray structure of Mycobacterium tuberculosis nucleoside diphosphate kinase. ,

13.

(2000) Mapping and identification of Mycobacterium tuberculosis proteins by two-dimensional gel electrophoresis,

14.

(2003) Singh Y. Cytotoxic activity of nucleoside diphosphate kinase secreted from Myco� bacterium tuberculosis.,

15.

(2000) Towards the proteome of Mycobacterium tuberculosis,

16.

(clonalantibodies.jimmunol1985) Raison RL. Mycobacterium leprae antigens involved in human responses identification of four antigens by mono�,

17.

(2001) The application of proteomics in defining the T cell antigens of Mycobacterium tuberculosis,

18.

(1997) Adjuvant modulation of immune res ponses to tuberculosis subunit vaccines,

19.

(1994) Effective vaccination of mice against Mycobacterium tuberculosis infection with a soluble mixture of secreted mycobacterial proteins,

20.

(1998) Is IgG2a a good Th1 marker in mice,

21.

(2001) Protection of mice with a tuberculosis subunit vaccine based on a fusion protein of antigen 85b and east-6,

22.

(2001) Overexpression of heat-shock proteins reduces survival of Mycobacterium tuber culosis in the chronic phase of infection,

23.

(2004) induce T-helper responses and protect against live challenge in a murine aerosol challenge model of pulmonary tuberculosis,

24.

(2003) Evaluation of adjuvants for protein vaccines against tuberculosis in guinea pig,

25.

(2002) Oral vaccination with subunit vaccines protects animals against aerosol infection with Mycobacterium tuberculosis,

Tuberculosis & Respiratory Diseases

e-Submission OA Policy